‘Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.’
OUT-LAW.com, 13th March 2018
Source: www.out-law.com
‘Manufacturers of branded medicines face new statutory controls on the cost of their drugs to the NHS in the UK from 1 April.’
OUT-LAW.com, 13th March 2018
Source: www.out-law.com